%D9%81%D9%84%D9%8A%D8%A8%D8%A7%D9%86%D8%B3%D8%B1%D9%8A%D9%86%D9%81%D9%84%DB%8C%D8%A8%D8%A7%D9%86%D8%B3%D8%B1%DB%8C%D9%86FlibanserinaCategory:FlibanserinFlibanserinFlibanserinFlibanserinFlibanserina%D9%81%D9%84%DB%8C%D8%A8%D8%A7%D9%86%D8%B3%D8%B1%DB%8C%D9%86FlibanseriiniFlibans%C3%A9rineFlibanserinFlibanserynaFlibanserina%D0%A4%D0%BB%D0%B8%D0%B1%D0%B0%D0%BD%D1%81%D0%B5%D1%80%D0%B8%D0%BDFlibanzerinFlibanzerin%D0%A4%D0%BB%D1%96%D0%B1%D0%B0%D0%BD%D1%81%D0%B5%D1%80%D0%B8%D0%BDFlibanserinQ415996%E6%B0%9F%E7%8F%AD%E8%89%B2%E6%9E%97
about
P3781
The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.Hypoactive sexual desire disorder: inventing a disease to sell low libido.Sex drive and sexual desire.Flibanserin: First Global Approval.Why are there no FDA-approved treatments for female sexual dysfunction?Flibanserin-Stimulated Partner Grooming Reflects Brain Metabolism Changes in Female Marmosets.Determination of flibanserin and tadalafil in supplements for women sexual desire enhancement using high-performance liquid chromatography with tandem mass spectrometer, diode array detector and charged aerosol detector.Pharmaceutical Approval Update.Flibanserin for female sexual dysfunction.Treatment for hypoactive sexual desire.Evaluation and Management of Hypoactive Sexual Desire Disorder.U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire DisorderFlibanserin (Addyi) for hypoactive sexual desire disorder
P921
Q30278438-ED4C0723-1422-4E02-9232-9646F00C0F32Q33166265-6AF4AFE1-313C-4840-9085-95E07EFA4FF5Q33166596-331AA542-F340-4F6A-8093-7B441E66060EQ34043125-B07F87F6-53C9-4878-9002-1C7D63F344B2Q34657890-A618EBE5-9EBE-4AAE-9D71-A928126C1FBEQ34671066-07C8D272-ACDE-4F42-8FB6-A56D591B4547Q38588740-77A1646C-DE22-4776-B887-7407777F8E35Q38594117-CC80790B-2825-421F-B950-C2FD77F69DC7Q47566021-8040FCF6-9A97-463D-A112-69E5C65EF4CCQ48094293-5DA051D3-172A-4644-ADA7-BD53BEF146A4Q50721510-E4554F71-D8F7-4588-9078-B2F5DA802ACFQ50943754-AA3298E8-985F-4BBB-9198-CA1C79994357Q51115752-BD467FB0-2001-4DCB-B50B-A50F71DE117CQ52147615-0890E666-26B8-4705-BDF1-2BBA2A450954Q53437731-7ECD4E32-C471-4904-8D89-323F950C165CQ56966215-2EEC31D8-DC46-4F8B-955E-117F7AAD5DBEQ86170211-DD273288-9DCC-4C10-8048-80268A297106
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Flibanseriini
@fi
Flibanserin
@da
Flibanserin
@de
Flibanserin
@it
Flibanserin
@nl
Flibanserin
@vi
Flibanseryna
@pl
Flibanzerin
@sh
Flibanzerin
@sr-el
flibanserin
@en
type
label
Flibanseriini
@fi
Flibanserin
@da
Flibanserin
@de
Flibanserin
@it
Flibanserin
@nl
Flibanserin
@vi
Flibanseryna
@pl
Flibanzerin
@sh
Flibanzerin
@sr-el
flibanserin
@en
altLabel
1,3-Dihydro-1-(2-(4-(3-(triflu ...... l)ethyl)-2H-benzimidazol-2-one
@en
1-(2-(4-alpha,alpha,alpha-Trifluoro-m-tolyl)-1-(piperazinyl)ethyl)-2-benzimidazolinone
@en
Addyi®
@en
BIMT 17 BS
@en
BIMT-17
@en
BIMT-17
@pt
BIMT-17
@sr
Bimt 17
@en
C20H21F3N4O
@sr
Female Viagra (Street Name)
@en
prefLabel
Flibanseriini
@fi
Flibanserin
@da
Flibanserin
@de
Flibanserin
@it
Flibanserin
@nl
Flibanserin
@vi
Flibanseryna
@pl
Flibanzerin
@sh
Flibanzerin
@sr-el
flibanserin
@en